European Journal of Nanomedicine Jump to ContentJump to Main Navigation
Show Summary Details

European Journal of Nanomedicine

Editor-in-Chief: Hunziker, Patrick / Mollenhauer, Jan

Managing Editor: Löffler, Beat / Salieb-Beugelaar, Georgette

Editorial Board Member: Alexiou, Christoph / Balogh, Lajos / Barenholz, Yechezkel / Dawson, Kenneth / Fadeel, Bengt / Husseini, Ghaleb / Krol, Silke / Lee, Dong Soo / Lehr, Claus-Michael / Mangge, Harald / Müller, Bert / Peer, Dan / Scoles, Giacinto / Serruys, Patrick / Schwartz, Simo / Szebeni, Janos

SCImago Journal Rank (SJR) 2015: 0.355
Source Normalized Impact per Paper (SNIP) 2015: 0.436
Impact per Publication (IPP) 2015: 1.227

    99,00 € / $149.00 / £75.00*

    See all formats and pricing

    Select Volume and Issue
    Loading journal volume and issue information...


    Free Trial Access Available!

    Our editorial team has compiled 40 of our most interesting articles and book chapters from across our entire portfolio.
    Read and download them for free
    Plus: Test our new Nano Database for free!

    Your Benefits

    • Multidisciplinary approach to human diseases with nanoscience
    • Special attention to niches in the subject matter of EJNM
    • Wide audience – academic and beyond
    • Free access to all manuscripts published in 2015
    • Online publication ahead of print

    Aims and Scope

    The European Journal of Nanomedicine (EJNM) is a peer-reviewed quarterly journal dedicated to basic and clinical research in Nanomedicine. Its focus lies on the clinical application of nanoscience tools, methods and materials and on the exploration of the implications of Nanomedicine. EJNM covers topics from nano(bio)technological engineering and characterization to clinically translatable innovative prevention, diagnostics, and therapies of major as well as neglected human diseases. It addresses a multidisciplinary readership and provides a comprehensive outlook on the application of nanosciences for the benefit of patients.

    • Experimental, Analytical, (Pre-)Clinical, Preventive and Therapeutic Nanomedicine
    • Medical Nanomaterials
    • Nanobiotechnology
    • Nanodiagnostics
    • Nanotoxicity
    • Nano-Imaging Technologies
    • Vanguard Nano-Technologies
    • Implementation and Implications of Nanomedicine
    • Personalized Nanomedicine

    Article formats
    • Original Articles
    • Reviews
    • Short Communications
    • Opinion Papers
    • Letters to the Editor

    Information on submission process


    Type of Publication:

    scientists in chemistry, physics, engineering, pharmacology, molecular biology, biomedicine, and clinicians, addressing recipients in academic, industrial, and regulatory environments, the informed public and policymakers

    Submission of Manuscripts

    Instructions for Authors

    You can easily submit your manuscript online. You will be guided through the whole peer-reviewing and publishing process.

    Your benefits of publishing with us
    • Easy-to-use online submission, peer-review, and publication system
    • Short turnaround times: Authors’ notification within approx. 4 weeks from submission date, revised manuscripts to be returned after 6 weeks maximum
    • High quality independent peer-review
    • Every article easily discoverable because of SEO and comprehensive abstracting and indexing services
    • Convenient citation tracking via e-mail alert
    • Secure archiving by De Gruyter and the independent archiving service Portico
    • Professional sales and marketing activities
    Submission process
    • Submission of your paper via our submission management tool
    • Peer review process (step by step guidance)
    • Quick decision on your paper
    • If accepted: you have the option to publish it open access
    • Publication online and in print – online ahead of print as well

    Please note
    • Where applicable, all authors must confirm in writing that they have complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects and/or animals. In the Materials and Methods Section, or in a separate section, the manuscript should contain a statement that the study has been approved by the Ethical Committee of the institution where the study was performed, and that the study subjects, or their legal guardians, gave informed consent for participation in the study. Before submitting your article please have a look at our Publication Ethics and Malpractice Statement and our copyright agreement
    • The ethics statements for the European Journal of Nanomedicine are based on the Committee on Publication Ethics (COPE) Best Practice Guidelines for Journal Editors and the “Uniform Requirements for Manuscripts (URM) Submitted to Biomedical Journals” of the International Committee of Medical Journal Editors
    • Once your article is accepted you have the option to publish it open access
    • Our repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract
    • If you have any general questions please visit our FAQ page for authors
    Additional information for manuscript formatting
    • Please avoid footnotes in the text, use parentheses instead
    • Original articles should not exceed 6,000 words, including references, and should not occupy more than 7- 10 printed pages (one printed page is approx. 4000 characters)
    • Communications should not exceed 3 printed pages. Each full page of printed text corresponds to approximately 800 words. Allow space for tables and illustrations within the page limit (each table or illustration accounts usually for approx. a half printed page)
    • Articles should have Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Acknowledgements and List of non-standard abbreviations (if applicable), References, Table and Figure Legends, if applicable
    • Original Articles and Reviews should be submitted along with a photograph and a short biography (6-10 lines, written in 3rd person) of the corresponding author and all co-author(s). This information will be published after the References
    • Graphical Abstract – an eye-catching graphic for the Table of Contents (5 cm wide and 5 cm high) should be provided at the end of each manuscript along with a max. length of 30 words with a text different from the abstract. This text should show the attraction points of your work
    • Reference lists have to be written in Vancouver style
    • The names of journals should be abbreviated according to the World List of Scientific Periodicals
    • Number the references consecutively in the order in which they appear in the text, including tables and figures. In the body-text, identify references by Arabic numerals in round brackets (1). In the references all authors must be included; et al. is not accepted. Do not use italic font in the reference section
    • If you use a reference managing program you could apply the New England Journal of Medicine style to your manuscript
    • For more detailed information please see: or contact the EJNM Editorial Office

    We look forward to receiving your manuscript!

    More ...


    EJNM was founded in 2008 as the official publishing organ of the CLINAM (European Foundation for Clinical Nanomedicine)

    The first issue of Volume 4 in 2012 was the first to be published at De Gruyter

    Other publications in the field

    Abstracting & Indexing

    European Journal of Nanomedicine is covered by the following services:

    • Baidu Scholar
    • Celdes
    • Chemical Abstracts Service (CAS) - CAplus
    • Chemical Abstracts Service (CAS) - SciFinder
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Elsevier - Compendex
    • Elsevier - Engineering Village
    • Elsevier - SCOPUS
    • Genamics JournalSeek
    • Google Scholar
    • J-Gate
    • JournalTOCs
    • Meta (formerly Sciencescape)
    • Naviga (Softweco)
    • Paperbase
    • Pirabase
    • Polymer Library
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • ReadCube
    • ResearchGate
    • SCImago (SJR)
    • Summon (Serials Solutions/ProQuest)
    • TDOne (TDNet)
    • Thomson Reuters - Emerging Sources Citation Index
    • Ulrich's Periodicals Directory/ulrichsweb
    • WorldCat (OCLC)

    Editorial Information

    Patrick Hunziker, University Hospital Basel, Switzerland
    Jan Mollenhauer, University of Southern Denmark, Odense, Denmark

    Scientific Managing Editor
    Georgette Salieb-Beugelaar, University Hospital Basel, Switzerland

    Managing Editor CLINAM
    Beat Löffler, European Foundation for Clinical Nanomedicine, Basel, Switzerland

    Christoph Alexiou, University Hospital Erlangen, Germany
    Yechezkel Barenholz, The Hebrew University of Jerusalem, Israel
    Kenneth Dawson, University College Dublin, Ireland
    Rutledge Ellis-Behnke, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
    Bengt Fadeel, Karolinska Institutet, Stockholm, Sweden
    Silke Krol, Neurological Institute Foundation Carlo Besta, Milan, Italy
    Dong Soo Lee, Seoul National University, Seoul, South Korea
    Claus-Michael Lehr, Saarland University, Saarbrücken, Germany
    Eder-Lilia Romero, Quilmes National University, Bernal, Buenos Aires, Argentina
    Simó Schwartz, Vall d'Hebron University Hospital, Barcelona, Spain
    Janos Szebeni, Semmelweis University, Budapest, Hungary

    Editorial Board
    Ghaleb Husseini, American University of Sharjah, Sharjah, United Arab Emirates
    Harald Mangge, Medical University of Graz, Graz, Austria
    Bert Müller, University of Basel, Switzerland
    Dan Peer, Tel Aviv University, Tel Aviv, Israel
    Giacinto Scoles, Princeton University, Princeton, New Jersey, USA
    Patrick W. Serruys, Erasmus University Medical Center, Rotterdam, The Netherlands

    Editorial Advisor
    Lajos Balogh, AA Nanomedicine & Nanotechnology Consultants, Boston, Massachusetts, USA

    Editorial Office - Contact
    Alexandra Hinz
    De Gruyter
    Genthiner Straße 13
    10785 Berlin
    Tel.: +49 (0)30 260 05 - 358
    Fax: +49 (0)30 260 05 - 325

    Comments (0)

    Please log in or register to comment.